Said, B. N., Heysell, S. K., Yimer, G., Aarnoutse, R. E., Kibiki, G. S., Mpagama, S., & Mbelele, P. M. (2021). Pharmacodynamic Biomarkers for Quantifying the Mycobacterial Effect of High Doses of Rifampin in Patients with Rifampin-susceptible Pulmonary Tuberculosis. Int J Mycobacteriol.
Chicago Style citaatSaid, Bibie N., Scott K. Heysell, Getnet Yimer, Rob E. Aarnoutse, Gibson S. Kibiki, Stellah Mpagama, en Peter M. Mbelele. "Pharmacodynamic Biomarkers for Quantifying the Mycobacterial Effect of High Doses of Rifampin in Patients With Rifampin-susceptible Pulmonary Tuberculosis." Int J Mycobacteriol 2021.
MLA citatieSaid, Bibie N., et al. "Pharmacodynamic Biomarkers for Quantifying the Mycobacterial Effect of High Doses of Rifampin in Patients With Rifampin-susceptible Pulmonary Tuberculosis." Int J Mycobacteriol 2021.